Showing results (341-350 of 1,783) with videos related to

Sort By:
Pageof 179
Dermatology and Therapy|August 16, 2025
Clinical Characteristics of Super Responders to Anti-IL-4Rα Biologic Therapy in Atopic DermatitisLitian Zhang, Linglu Fang, Kun Zhong, et al.
Dermatology and Therapy|September 11, 2025
Optimizing Psoriasis Treatment with Tildrakizumab: Current Evidence and Expert Recommendations for Treatment Individualization in Clinical PracticeRicardo Ruiz-Villaverde, Almudena Mateu, Pedro Mendes-Bastos, et al.
Dermatology and Therapy|August 8, 2025
The Urticaria Voices Study: Physicians' Perspectives on the Real-World Patient Burden, Treatments, and Outcomes in Chronic Spontaneous UrticariaKarsten Weller, Tonya A Winders, Jessica McCarthy, et al.
Dermatology and Therapy|August 12, 2025
Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative ReviewKatherine Sanchez, Hanna Englander, Lana Salloum, et al.
Dermatology and Therapy|February 16, 2026
Pediatric Psychodermatology: Advancing Therapy through Integrated CareBrianna Sa, Nicole Khalil, Elise Edwards, et al.
Dermatology and Therapy|February 13, 2026
Efficacy and Safety of Benvitimod Compared with Halometasone in Patients with Moderate-to-Severe Chronic Hand Eczema: A Prospective, Single-Center, Parallel-Group, Open-Label Randomized TrialYuan Chang, Gongfeng Tang, Haixuan Wu, et al.
Dermatology and Therapy|February 17, 2026
Prebiotics, Probiotics, and Postbiotics for Acne Vulgaris: A Systematic ReviewPeyton V Warp, Sophie M Bilik, Lina M Ferrari, et al.
Dermatology and Therapy|June 16, 2025
Effect of a Photolyase-Based Medical Device on Actinic Keratosis in Phototypes III-IV Patients: Real-Life Clinical SettingFernando Bulla, Susana Mejía, Sebastian Gil-Quiñones, et al.
Dermatology and Therapy|June 15, 2025
Investigation of the Efficacy and Safety of Xeligekimab (GR1501) in Patients with Moderate-to-Severe Plaque Psoriasis: A Multicenter, Randomized, Double-Blind Phase II Clinical trialLin Cai, Chengxin Li, Shanshan Li, et al.
Dermatology and Therapy|March 29, 2025
Efficacy and Safety of Ruxolitinib Cream in Vitiligo by Patient Characteristic Subgroups: Descriptive Pooled Analysis From Two Phase 3 StudiesJulien Seneschal, Albert Wolkerstorfer, Seemal R Desai, et al.
Pageof 179